Incyte to Report First Quarter 2010 Financial Results and Provide Update on Drug Discovery & Development Programs on May 6
April 22 2010 - 4:30PM
Business Wire
Incyte Corporation (Nasdaq: INCY) announced today that it has
scheduled its first quarter 2010 financial results conference call
for 8:30 a.m. ET on Thursday, May 6, 2010. The schedules for the
press release and conference call are as follows:
-- Q1 2010 Press Release:
May 6, 2010 at 7:00 a.m. ET -- Q1 2010
Conference Call: May 6, 2010 at 8:30 a.m. ET -- Domestic
Dial In Number: 877-407-8037 -- International Dial In
Number: 201-689-8037 -- Conference ID # 349566
If you are unable to participate, a replay of the conference
call will be available for thirty days. The replay dial-in number
for the U.S. is 877-660-6853 and dial-in number for international
callers is 201-612-7415. To access the replay you will need the
conference account number 278 and the ID number 349566.
The conference call will also be webcast live on CCBN and can be
accessed at www.incyte.com under Investor Relations, Events and
Webcasts.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based drug
discovery and development company focused on developing proprietary
small molecule drugs for oncology, inflammation and diabetes.
Incyte’s most advanced compound, INCB18424, is in Phase III
development for myelofibrosis. For additional information on
Incyte, visit the Company's web site at www.incyte.com.
Incyte (NASDAQ:INCY)
Historical Stock Chart
From May 2024 to Jun 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jun 2023 to Jun 2024